SCHEMBL5711269

SCHEMBL5711269

CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)N1CSC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)c1nc2ccccc2o1

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 15/20 0.49
ELANE P08246 4/20 0.47
CTRC Q99895 2/20 0.45
CTSS P25774 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5711290 0.91 PRSS8 (0.49) ELANECTSS
SCHEMBL5711275 0.86 PRSS8 (0.45) CTSS
SCHEMBL5711349 0.86 CMA1 (0.50) CMA1CTRC
SCHEMBL7661082 0.85 CMA1 (0.44) CMA1ELANECTSS
SCHEMBL7668464 0.85 CMA1 (0.44) CMA1ELANECTRC
SCHEMBL5711189 0.85 CMA1 (0.49) CMA1CTRC
SCHEMBL5711368 0.83 CMA1 (0.51) CMA1CTRC
SCHEMBL5711366 0.83 CMA1 (0.58) CMA1CTRC
SCHEMBL5711273 0.82 CMA1 (0.65) CMA1ELANECTRC
SCHEMBL5711268 0.82 CMA1 (0.65) CMA1ELANECTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103560-B1 NOVEL THIAZOLIDINE DERIVATIVES SANTEN PHARMACEUTICAL CO LTD (JP) 2006-12-27 EP disclosed
US-6410576-B1 ANTIINFLAMMATORY AGENTS; CARDIOVASCULAR DISORDERS SANTEN PHARMACEUTICAL CO., LTD. (JP) 2002-06-25 US disclosed
EP-1103560-A1 NOVEL THIAZOLIDINE DERIVATIVES SANTEN PHARMACEUTICAL CO., LTD. (JP) 2001-05-30 EP disclosed